| Literature DB >> 17197177 |
Francis Beaulieu1, Carl Ouellet, Edward H Ruediger, Makonen Belema, Yuping Qiu, Xuejie Yang, Jacques Banville, James R Burke, Kurt R Gregor, John F MacMaster, Alain Martel, Kim W McIntyre, Mark A Pattoli, F Christopher Zusi, Dolatrai Vyas.
Abstract
We have recently identified BMS-345541 (1) as a highly selective and potent inhibitor of IKK-2 (IC50 = 0.30 microM), which however was considerably less potent against IKK-1 (IC50 = 4.0 microM). In order to further explore the SAR around the imidazoquinoxaline tricyclic structure of 1, we prepared a series of tetracyclic analogues (7, 13, and 18). The synthesis and biological activities of these potent IKK inhibitors are described.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17197177 DOI: 10.1016/j.bmcl.2006.12.017
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823